Dr Reddy's says US FDA has issued Form 483 for Srikakulam API plant
The US FDA has completed its inspection of Dr Reddy’s API plant in Srikakulam, Andhra Pradesh and issued the firm with a Form 483 detailing two observations.
The US FDA has completed its inspection of Dr Reddy’s API plant in Srikakulam, Andhra Pradesh and issued the firm with a Form 483 detailing two observations.
The global contract research organization (CRO) has announced an expanded clinical research service offering after merging with Medelis last year.
Envigo has launched a mixed-background mouse to support oncology, immuno-oncology, and infectious disease research.
Shangpharma plans to merge its API unit with its research arm as Shanghai Chempartner, which it will list on the Shanghai or Shenzhen stock exchange.
Parexel’s new patient sensor solution aims to capitalize on remote clinical trial data collected via medical devices.
Alkem Laboratories Ltd says the US FDA has accepted its plan to bring its API plant in Ankaleshwar, India up to code.
The International Air Transport Association (IATA) has certified a DHL air freight station in Leipzig, Germany for the cold storage and shipment of APIs and finished pharmaceuticals.
Paid for and content provided by World Courier
World Courier shares how logistics can make or break a cell or gene therapy trial.